Found: 15
Select item for more details and to access through your institution.
Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity.
- Published in:
- EMBO Journal, 2006, v. 25, n. 4, p. 683, doi. 10.1038/sj.emboj.7600991
- By:
- Publication type:
- Article
Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139715
- By:
- Publication type:
- Article
Toll-Like Receptor 9 Mediated Responses in Cardiac Fibroblasts.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104398
- By:
- Publication type:
- Article
The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033038
- By:
- Publication type:
- Article
Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice.
- Published in:
- Mediators of Inflammation, 2017, p. 1, doi. 10.1155/2017/9450439
- By:
- Publication type:
- Article
Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01285
- By:
- Publication type:
- Article
A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury? Reply.
- Published in:
- Cardiovascular Research, 2013, v. 99, n. 1, p. 226, doi. 10.1093/cvr/cvt130
- By:
- Publication type:
- Article
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury.
- Published in:
- Cardiovascular Research, 2013, v. 99, n. 1, p. 164, doi. 10.1093/cvr/cvt091
- By:
- Publication type:
- Article
HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases.
- Published in:
- Journal of Internal Medicine, 2023, v. 293, n. 5, p. 648, doi. 10.1111/joim.13616
- By:
- Publication type:
- Article
Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 3, p. 477, doi. 10.1111/joim.13495
- By:
- Publication type:
- Article
Cellular sources and inducers of cytokines present in acute wound fluid.
- Published in:
- Wound Repair & Regeneration, 2011, v. 19, n. 3, p. 337, doi. 10.1111/j.1524-475X.2011.00668.x
- By:
- Publication type:
- Article
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0188387
- By:
- Publication type:
- Article